Chemistry: molecular biology and microbiology – Animal cell – per se ; composition thereof; process of... – Primate cell – per se
Reexamination Certificate
2011-03-15
2011-03-15
Belyavskyi, Michail A (Department: 1644)
Chemistry: molecular biology and microbiology
Animal cell, per se ; composition thereof; process of...
Primate cell, per se
C435S374000, C435S375000
Reexamination Certificate
active
07906331
ABSTRACT:
The present invention includes methods of identifying and/or isolating stem cells based on expression of BCRP. The present invention also describes methods of obtaining and/or using cell populations enriched for stem cells. In addition, methods are provided for diagnosing and/or prognosing leukemia, particularly human acute myelogenous leukemia (AML), through assaying for BCRP expression in leukemic cells.
REFERENCES:
patent: 4281061 (1981-07-01), Zuk et al.
patent: 5563247 (1996-10-01), Niman et al.
patent: 5571687 (1996-11-01), Casey et al.
patent: 5994088 (1999-11-01), Mechetner et al.
patent: 6313277 (2001-11-01), Ross et al.
patent: 6485933 (2002-11-01), Bandman et al.
patent: 6528623 (2003-03-01), Godfrey et al.
patent: 9324613 (1993-12-01), None
patent: 9716535 (1997-05-01), None
patent: 9812304 (1998-03-01), None
patent: 9940110 (1999-08-01), None
patent: 9961589 (1999-12-01), None
Bunting, Stem Cells, 2002, v.20, pp. 11-20.
Doyle 2003, Oncogene, 2003, 22, pp. 7340-7358.
Zhou et al (Natural Medicine, 2001, v.7, pp. 1028-1034.
Geschwind et al., Neuron, 2001, v.29, pp. 325-339.
Owens et al., J of Immunological methods, 1994, vol. 168; p. 149-165.
Kohler et al., Eur J. Immunol 1976; 6511-9.
Datasheet for clone 4E3 antibody, DAKO Corp. 2004.
Arcesi et al., Cancer Res. 1993; 53:310-7.
Scheffer et al., Proc AM Assoc Cancer Res 2000; 41:803.
Allen et al., “The mouse Bcrp1/Mxr/Abcp gene: amplification and overexpression in cell lines selected for resistance to topotecan, mitoxantrone, or doxorubicin”, Cancer Res., 59: 4237-41. 1996.
Allikmets et al., “Characterization of the human ABC superfamily: isolation an mapping of 21 new genes using the expressed sequence tags database” Hum Mol Genet 5: 1649-55. 1996.
Bhatia et al., Nat Med., 186: 619-624; 1997.
Bhatia et al., “A newly discovered class of human hematopoietic cells with SCID-repopulating activity”, Nat Med., 4: 1038-45, 1998.
Brongi et al., Cancer Research, 59:5938-5946, 1999.
Bunting et al., “Transduction of murine bone marrow cells with and MDR1 vector enables ex vivo stem cell expansion but these expanded grafts cause a myeloproliferative syndrome in transplanted mice”, 1998, BLOOD, vol. 92, pp. 2269-2279.
Chaudhary and Roninson et al., Cell 66: 85-94, 1991.
Doyle et al., “A multidrug resistance transporter from human MCF-7 breast cancer cells”, Proc. Natl. Acad. Sci. USA 95: 15665-15670 (1998).
Galipeau, J, Benaim, E, Spencer, HT, Blakley, RL, & Sorrentino, BP. (1997). A bicistronic retroviral vector for protecting hematopoietic cells against antifolates and P-glycoprotein effluxed drugs. Hum Gene Ther, 8, 1773-83.
Giles et al., “Multidrug resistance protein expression in chronic myeloid leukemia: associations and signigicance”, Cancer, 86: 805-813, 1999.
Glimm and Eaves et al., Blood, 94: 2161-68, 1999.
Goodell et al., “Isolation and functional properties of murine hematopoietic stem cells that are replicating in vivo”, J Exp Med. 183: 1797-1806; 1996.
Gruol and Bourgeois et al., Biochem. Cell. Biol., 72: 561-71, 1994.
Gussoni et al., Nature, 401: 390-4; 1999.
Hanania EG, Deisseroth AB. et al., “Serial transplantation shows that early hematopoietic precursor cells are transduced by MDR-1 retroviral vector in a mouse gene therapy model”, Cancer Gene Ther. 1994;1:21-25.
Hanania et al., “Resistance to taxol chemotherapy produced in mouse marrow cells by safety-modified retroviruses containing a human MDR-1 transcription unit.”, Gene Ther., 2: 279-84, 1995.
Hrycyna CA, Airan LE, Germann UA, Ambudkar SV, Pastan I, Gottesman MM. Structural flexibility of the linker region of human P-glycoprotein permits ATP hydrolysis and drug transport. Biochemistry 1998;37:13660-73.
Jackson et al., PNAS USA 96: 14482-86; 1999.
Johnstone et al., Blood 93:1075-85; 1999.
Leith C, Kopecky K, Chen I, et al Frequency and clinical significance of the expression of the multidrug resistance proteins MDR1/P-glycoprotein, MRP1, and LRP in acute myeloid leukemia. A Southwest Oncology Group study. Blood 1999;94:1086-99.
Malieparard et al., Cancer Res., 59: 4559-63; 1999.
Michieli et al., Br. J. Jaematol, 104:328-335, 1999.
Miyake et al., “Molecular Cloning of cDNAs Which Are Highly Overexpressed in Mitoxantrone-resistant Cells”, Cancer Res., 59: 8-13, 1999.
Nakayama et al., “Hypomethylation status of CpG sites at the promoter region and overexpression of the human MDR1 gene in acute myeloid leukemias”, Blood, 92:4296-4307, 1998.
Osawa et al., Science, 273:242-45, 1996.
Persons et al., “Retroviral-Mediated Transfer of the Green Fluorescent Protein Gene Into Murine Hematopoietic Cells Fasilitates Scoring and Selection of Transduced in Vitro and Identification of genetically modified cells in vivo”, Blood, 90(5): 1777-1786, 1997.
Podda et al., PNAS USA 89:9676-80, 1992.
Robinson et al., “Human MDR1 protein overexpression delays the apoptotic cascade in Chinese hamster ovary fibroblasts.” Biochemistry 36: 11169-78, 1997.
Ross et al., “Expression of breast cancer resistance protein in blast cells from patients with acute leukemia”, Blood, 96 (1): 365-368; 2000.
Schinkel et al., PNAS USA, 94: 4028-33, 1997.
Sorrentino et al., “Selection of drug resistant bone marrow cells in vivo after retroviral transfer of human MDR1”, Science, 257:99-103, 1992.
Sorrentino et al., “Expression of retroviral vectors containing the human multidrug resistance 1 cDNA in hematopoietic cells of transplanted mice.” Blood, 86:491-501, 1995.
Spencer et al., Blood, 87:2579-87, 1996.
Tisdale et al., Blood, 92:1131-41, 1998.
Traycoff et al., Exp. Hermotol., 26:53-62; 1998.
Zandstra et al., “Cytokine manipulation of primitive human hematopoietic cell self-renewal.” Proc. Natl. Acad. Sci USA, 94:4698-4703, 1997.
Zanjani et al., Exp. Hernatol., 26: 353-60, 1990.
Ziegler et al., “KDR receptor: a key marker defining hematopoietic stem cells.”; Science, 285: 1553-8, 1999.
Bunting K.D. et al., “ABC Transporters as Phenotypic Markers and Functional Regulators of Stem Cells”, Stem Cells 2002, 20:11-20.
Wall et al., “The BCRP Gene Product Transports the Stem Cell Marker Hoechst 33342 and Function Depends upon the Amount of Protein and an Intact Walker A Motif”, Proceedings of the American Associateion for Cancer Research Annual;. vol. 42, 2001, p. 281. xp001093958.
Zhou et al., “The ABC transporter BcrpI/ABCG2 is expressed in a wide variety of stem cells and is a molecular determinant of the side-popularion phenotype” Nature Medicine 2001, 7(9):1028-1034.
Zhou et al., “Expression of the Breast Cancer Resistance Protein (BCRP) in Side Population (SP) Stem Cells, Natural Killer (NK) Lymphocytes, and Erythroid Cells”, Blood, 2000; 96(11):820a.
Schuetz John
Sorrentino Brian
Belyavskyi Michail A
Fish & Richardson P.C.
St. Jude Children's Research Hospital
LandOfFree
Methods for identifying stem cells expressing breast cancer... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Methods for identifying stem cells expressing breast cancer..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Methods for identifying stem cells expressing breast cancer... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2660029